Q3 2017 Holdings
Filed 2017-11-13 | 12 holdings | $246.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $94.7K | 3,820,462 | 38.4% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $81.3K | 1,672,714 | 33.0% |
| Epizyme, Inc.(EPZMEUR) | COM | 29428V104 | $29.4K | 1,543,108 | 11.9% |
| Alder BioPharmaceuticals, Inc.(ALDR1EUR) | COM | 014339105 | $12.8K | 1,043,832 | 5.2% |
| Insmed Incorporated(INSM) | COM | 457669307 | $9.4K | 300,000 | 3.8% |
| Acceleron Pharma Inc.(XLRN) | COM | 00434H108 | $9.1K | 244,756 | 3.7% |
| Juno Therapeutics, Inc. | COM | 48205A109 | $4.0K | 90,000 | 1.6% |
| Jounce Therapeutics, Inc.(JNCEEUR) | COM | 481116101 | $1.9K | 119,912 | 0.8% |
| Dermira, Inc.(DERMEUR) | COM | 24983L104 | $1.6K | 58,624 | 0.6% |
| Loxo Oncology, Inc. | COM | 548862101 | $1.3K | 14,300 | 0.5% |
| Orexigen Therapeutics, Inc. | COM | 686164302 | $1.1K | 523,132 | 0.4% |
| Zafgen, Inc. | COM | 98885E103 | $108 | 30,775 | 0.0% |